Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen P. F. Miller is active.

Publication


Featured researches published by Stephen P. F. Miller.


Developmental Neuroscience | 1991

Type C Niemann-Pick Disease: Use of Hydrophobic Amines to Study Defective Cholesterol Transport

Calvin F. Roff; Ehud Goldin; Marcella E. Comly; Adele Cooney; Anthony Brown; Marie T. Vanier; Stephen P. F. Miller; Roscoe O. Brady; Peter G. Pentchev

Niemann-Pick Type C (NPC) disease is a cholesterol lipidosis resulting from defective postlysosomal cholesterol transport. In normal cells this segment of cholesterol trafficking is inhibited by treatment with either U18666A or imipramine. Other compounds are also capable of blocking postlysosomal cholesterol transport: stearylamine, RV-538, and sphinganine inhibit low-density lipoprotein-induced esterification of cholesterol and cause unesterified cholesterol to accumulate in perinuclear vesicles. These vesicles can be stained with filipin to give a staining pattern indistinguishable from that seen in NPC fibroblasts. Because all of these compounds are hydrophobic amines, we conclude that most, if not all, hydrophobic amines block the postlysosomal transport of cholesterol. These results also raise the possibility that an endogenous amine, e.g., sphinganine, may inhibit cholesterol transport in NPC.


Biochimica et Biophysica Acta | 1992

Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver.

Ehud Goldin; Calvin F. Roff; Stephen P. F. Miller; Claire Rodriguez-Lafrasse; Marie T. Vanier; Roscoe O. Brady; Peter G. Pentchev

We have determined the levels of free sphingoid bases in livers of normal and cholesterol lipidotic Niemann-Pick type C mice. Hepatic sphingosine and sphinganine levels in affected mice (593 pmol/mg protein) were elevated more than 20-fold when compared to levels in age-matched normal mice (26 pmol/mg protein). Upon fractionation of mutant liver homogenates by differential centrifugation, most of the sphingoid bases sedimented with beta-hexosaminidase in the 9000 x g pellet. Co-sedimentation of sphingoid bases with a lighter beta-hexosaminidase peak in Percoll gradients suggests that these bases accumulate in lipid laden lysosomes. A cytosolic sphinganine kinase is the first enzyme in the degradative pathway of sphingoid base metabolism. Activity of this enzyme was partially deficient in crude mutant liver cytosolic extracts due to the presence of an inhibitory substance. Following molecular sieving of mutant cytosolic extracts on Sepharose 4B, sphinganine kinase, with normal levels of activity, was resolved from a complex higher-molecular-weight inhibitor fraction. The Km values for either sphinganine or ATP-Mg substrates with partially purified sphinganine kinase from normal and mutant mouse liver extracts, were similar. These findings indicate that accumulation of free sphingoid bases is not due to a direct inherent deficiency in the catalytic activity of sphinganine kinase. The possible cause and effect relationship between the accumulation of these endogenous hydrophobic amines and the lesion in intracellular cholesterol trafficking in Niemann-Pick type C disease is discussed.


Tetrahedron Letters | 1987

The chemical identification of the granary weevil aggregation pheromone

Joel K. Phillips; Stephen P. F. Miller; John F. Andersen; Henry M. Fales; Wendell E. Burkholder

Abstract (R*,S*)-1-Ethylpropyl 2-methyl-3-hydroxypentanoate is identified as the major component of the aggregation pheromone of Sitophilus granarius (L.), the granary weevil.


Tetrahedron Letters | 1994

Synthesis of an inhibitor of sphingosine-1-phosphate lyase

Ahcene Boumendjel; Stephen P. F. Miller

Abstract The 2-vinyl dihydrosphingosine-1-phosphate 1 was synthesized and tested for inhibition of sphingosine-1-phosphate lyase. The carbon skeleton was prepared by acylation of a methionine imine with N-methoxy-N-methyl palmitamide. The vinyl group was generated by thermal sulfoxide elimination. Reduction of both carbonyl groups and deprotection gave 2-vinyl dihydrosphingosine. The phosphate group was introduced by means of bis(2-cyanoethyl)-N,N-diisopropyl-phosphoramidite as monofunctional phosphitylation reagent.


Journal of The Chemical Society-perkin Transactions 1 | 1988

Structural elucidation of alfalfa root saponins by mass spectrometry and nuclear magnetic resonance analysis

Georges Massiot; Catherine Lavaud; Louisette Le Men-Olivier; Georges Van Binst; Stephen P. F. Miller; Henry M. Fales

Structures of saponins may be fully elucidated using a combination of n.m.r. and m.s. instead of the usual degradation techniques. Well resolved proton n.m.r. spectra and chromatographic separation can be obtained from peracetylated mixtures of saponins. Under these conditions, genins are identified mainly by 13C n.m.r. spectroscopy; sugars and their points of attachment are determined by examining 1H chemical shifts and coupling constants following assignments made by 2D COSY and relayed COSY experiments. Sugar chains are sequenced by observing intersugar connectivities through long-range couplings (delayed COSY) or n.o.e. Alternatively, the use of Californium plasma desorption m.s. provides quasimolecular ions and fragments corresponding to the sequential rupture of the chain of sugars. Free carboxylic acids are located on an acetylated saponin by looking at the disappearance, in the presence of Eu complexes, of the carbon situated α to the carbonyl in the 13C n.m.r. spectrum. The above methods have been employed to determine the structures of the seven major saponins of alfalfa root, which are allegedly responsible for the antifeedant properties of the vegetable.


Tetrahedron | 1994

Synthesis and inhibitory activity of difluoroketone substrate analogs of N-myristoyltransferase.

Karen M. Neder; Stephanie French; Stephen P. F. Miller

Abstract Two fluorinated nonhydrolyzable analogs of myristoyl-coenzyme A were synthesized and tested for inhibitory activity against N-myristoyltransferase (NMT).S-(2,2-Difluoro-3-oxohexadecyl)-coenzyme A (3) and S-(3,3-difluoro-2-oxopentadecyl)-coenzyme A (2) were prepared by alkylation of coenzyme A and were purified by reverse phase chromatography. Inhibition of NMT was observed with 3 and 2, with IC50s of 110 nM and 80 nM, respectively, in an in vitro assay developed in our laboratory. The known unfluorinated analog S-(2-oxopentadecyl)-coenzyme A (1) was found to have an IC50 of 7 nM. At 100 μM in D2O, 3 was 59% hydrated and 2 was 88% hydrated.


Hepatology | 1993

Orthotopic liver transplantation in two adults with Niemann-Pick and Gaucher's diseases: implications for the treatment of inherited metabolic disease.

Elizabeth J. Smanik; Anthony S. Tavill; Gretta H. Jacobs; Irwin A. Schafer; Lou Farquhar; Fredrick L. Weber; James T. Mayes; James A. Schulak; Mary Petrelli; Gregory C. Zirzow; Katharine L. Oliver; Stephen P. F. Miller; Roscoe O. Brady


Archive | 1994

Method for preparation of sphingoid bases

Ahcene Boumendjel; Stephen P. F. Miller


Journal of Lipid Research | 1994

Synthesis of sphingosine-1-phosphate and dihydrosphingosine-1-phosphate.

Ahcene Boumendjel; Stephen P. F. Miller


Advances in Enzymology and Related Areas of Molecular Biology | 1991

N5-(1-carboxyethyl)ornithine and related [N-carboxyalkyl]-amino acids : structure, biosynthesis, and function

John Thompson; Stephen P. F. Miller

Collaboration


Dive into the Stephen P. F. Miller's collaboration.

Top Co-Authors

Avatar

Ahcene Boumendjel

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Roscoe O. Brady

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Calvin F. Roff

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ehud Goldin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Henry M. Fales

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Peter G. Pentchev

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Stephanie French

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Adele Cooney

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ann B. Moser

Kennedy Krieger Institute

View shared research outputs
Top Co-Authors

Avatar

Anthony Brown

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge